Osaic Holdings
SXTP icon

Osaic Holdings’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Osaic Holdings’s Portfolio SXTP Stock Details SXTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43 Hold
25
– – ﹤0.01% 7688
2025
Q4 		$51 Hold
25
– – ﹤0.01% 7694
2025
Q3 		$141 Hold
25
– – ﹤0.01% 7728
2025
Q2 		$237 Hold
25
– – ﹤0.01% 7477
2025
Q1 		$184 Hold
25
– – ﹤0.01% 7177
2024
Q4 		$645 Buy
+25
New +$552 ﹤0.01% 6951

Other funds holding SXTP

KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $442M AUM 29.95% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Osaic Holdings's SXTP Position: Q1 2026 in Review

Osaic Holdings held its 60 Degrees Pharmaceuticals (SXTP) position steady in Q1 2026 at 25 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #7688.

Osaic Holdings first reported a position in SXTP in Q4 2024 and has held it in 6 quarters since. The position peaked at $645 in Q4 2024. 8 funds tracked by Wall St. Rank hold SXTP as of Q1 2026.

  • Osaic Holdings held 25 shares of 60 Degrees Pharmaceuticals worth $43 as of Q1 2026.
  • Osaic Holdings left its 60 Degrees Pharmaceuticals share count unchanged in Q1 2026.
  • 60 Degrees Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7688 holding.
  • Osaic Holdings first reported a position in 60 Degrees Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Osaic Holdings's 60 Degrees Pharmaceuticals position peaked at $645 in Q4 2024.
  • 8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.